NRGene Technologies Ltd (NRGN.TA)

505.00 +57.30 (+12.80%) At close: 05:13PM IDT

NRGene Technologies Ltd

Golda Meir Street
5th Floor
Ness Ziona 7403649
Israel
972 7 222 03750
https://www.nrgene.com

Sector(s): Technology
Industry: Software - Application
Full-time employees: 55

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Gil Ronen Ph.D.	Co-Founder, CEO & Director	406k	N/A	1968
Mr. Udi Belder	Chief Financial Officer	303k	N/A	1984
David Radolsky	Accountant	N/A	N/A	1985
Dr. Kobi Baruch Ph.D.	Chief Technology Officer	N/A	N/A	1976
Yana Voldman	Marketing Director	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in ILA.

Description

NRGene Technologies Ltd, an AI genomics company, provides computational tools and develops advanced algorithms in North America, Europe, Middle East, Africa, Asia Pacific, and internationally. It offers software tools; and turnkey solutions to breeding agricultural and food technology companies, academia, research institutes, and agribiotech companies. The company also develops custom panels for various plants including wheat, canola, corn, soybean, maize, etc., as well as cannabis. NRGene Technologies Ltd was incorporated in 2009 and is based in Ness Ziona, Israel.

Corporate governance

NRGene Technologies Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.